These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38457031)

  • 1. Left ventricular hypertrophy and left atrial diameter are associated with mortality risk in haemodialysis patients: a retrospective cohort study.
    Bai J; Huang W; Zhang Y; Wei L; Zhao C; Ren Z; Wang Q; Ren K; Cao N
    Clin Exp Nephrol; 2024 Jul; 28(7):683-691. PubMed ID: 38457031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease.
    de Roij van Zuijdewijn CL; Hansildaar R; Bots ML; Blankestijn PJ; van den Dorpel MA; Grooteman MP; Kamp O; ter Wee PM; Nubé MJ
    Am J Nephrol; 2015; 42(2):126-33. PubMed ID: 26382055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses.
    Mimura I; Nishi H; Mise N; Mori M; Sugimoto T
    Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease.
    Payne J; Sharma S; De Leon D; Lu JL; Alemu F; Balogun RA; Malakauskas SM; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2012 Feb; 27(2):694-700. PubMed ID: 21613387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left Ventricular Hypertrophy Geometry and Vascular Calcification Co-Modify the Risk of Cardiovascular Mortality in Patients with End-Stage Kidney Disease: A Retrospective Cohort Study.
    Chao CT; Liao MT; Wu CK
    J Atheroscler Thromb; 2023 Sep; 30(9):1242-1254. PubMed ID: 36567124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation.
    Patel RK; Jardine AG; Mark PB; Cunningham AF; Steedman T; Powell JR; McQuarrie EP; Stevens KK; Dargie HJ; Jardine AG
    Am J Kidney Dis; 2010 Jun; 55(6):1088-96. PubMed ID: 20346559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Geometry and Inferior Vena Cava Diameter Co-Modify the Risk of Cardiovascular Outcomes in Chronic Hemodialysis Patients.
    Wu CK; Wang M; Kao ZK; Yar N; Chuang MT; Chang TH
    Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064569
    [No Abstract]   [Full Text] [Related]  

  • 8. Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients.
    Omae K; Ogawa T; Yoshikawa M; Nitta K
    Heart Vessels; 2012 Nov; 27(6):610-7. PubMed ID: 21953505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis.
    Hsieh HL; Hsu SC; Cheng HS; Chen CY; Huang WC; Sue YM; Lin FY; Shih CM; Chen JW; Lin SJ; Huang PH; Liu CT
    PLoS One; 2020; 15(1):e0228405. PubMed ID: 31999778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic left ventricular hypertrophy and outcome in hemodialysis patients.
    Kim SJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Kim HR; Park JT; Han SH; Yoo TH; Choi KH; Kang SW
    PLoS One; 2012; 7(4):e35534. PubMed ID: 22530043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
    Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
    Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study.
    Axelsson Raja A; Warming PE; Nielsen TL; Plesner LL; Ersbøll M; Dalsgaard M; Schou M; Rydahl C; Brandi L; Iversen K
    BMC Nephrol; 2020 Sep; 21(1):413. PubMed ID: 32977752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of quantitative analysis of left ventricular systolic function in patients on maintenance hemodialysis based on myocardial work technique.
    Liu C; Feng YP; Yan ZN; Fan L; Rui YF; Cui L
    BMC Cardiovasc Disord; 2021 Feb; 21(1):76. PubMed ID: 33549050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
    Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
    Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.
    Oguntola SO; Hassan MO; Duarte R; Vachiat A; Manga P; Naicker S
    BMC Nephrol; 2019 Oct; 20(1):399. PubMed ID: 31666030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
    Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
    Hsu HJ; Wu MS
    Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.